ReviewFrontiers in immunology2026

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications.

Ming-Zhu Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.